SEARCH

SEARCH BY CITATION

References

  • 1
    Billingham RE, Brent L, Medawar PB: Actively acquired tolerance of foreign cells. Nature 1953; 172:603606.
  • 2
    Guerin LR, Prins JR, Robertson SA: Regulatory T cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum Reprod Update 2009; 15:517535.
  • 3
    Matrougui K, Zakaria AE, Kassan M, Choi S, Nair D, Gonzalez-Villalobos RA, Chentoufi AA, Kadowitz P, Belmadani S, Partyka M: Natural Regulatory T cells control coronary arteriolar endothelial dysfunction in hypertensive mice. Am J Pathol 2011; 178:434441.
  • 4
    Sakaguchi S: Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005; 6:345352.
  • 5
    Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4:330336.
  • 6
    Aluvihare VR, Kallikourdis M, Betz AG: Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004; 5:266271.
  • 7
    Thuere C, Zenclussen ML, Schumacher A, Langwisch S, Schulte-Wrede U, Teles A, Paeschke S, Volk HD, Zenclussen AC: Kinetics of regulatory T cells during murine pregnancy. Am J Reprod Immunol 2007; 58:514523.
  • 8
    Shima T, Sasaki Y, Itoh M, Nakashima A, Ishii N, Sugamura K, Saito S: Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice. J Reprod Immunol 2010; 85:121129.
  • 9
    Darrasse-Jeze G, Klatzmann D, Charlotte F, Salomon BL, Cohen JL: CD4+CD25+ regulatory/suppressor T cells prevent allogeneic fetus rejection in mice. Immunol Lett 2006; 102:106109.
  • 10
    Zenclussen AC, Gerlof K, Zenclussen ML, Sollwedel A, Bertoja AZ, Ritter T, Kotsch K, Leber J, Volk HD: Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Am J Pathol 2005; 166:811822.
  • 11
    Jasper MJ, Tremellen KP, Robertson SA: Primary unexplained infertility is associated with reduced expression of the regulatory T cell transcription factor Foxp3 in endometrial tissue. Mol Hum Reprod 2006; 12:301308.
  • 12
    Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, Saito S: Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod 2004; 10:347353.
  • 13
    Arruvito L, Billordo A, Capucchio M, Prada ME, Fainboim L: IL-6 trans-signaling and the frequency of CD4+FOXP3+ cells in women with reproductive failure. J Reprod Immunol 2009; 82:158165.
  • 14
    Hanna N, Hanna I, Hleb M, Wagner E, Dougherty J, Balkundi D, Padbury J, Sharma S: Gestational age-dependent expression of IL-10 and its receptor in human placental tissues and isolated cytotrophoblasts. J Immunol 2000; 164:57215728.
  • 15
    Kalkunte S, Lai Z, Tewari N, Chichester C, Romero R, Padbury J, Sharma S: In vitro and in vivo evidence for lack of endovascular remodeling by third trimester trophoblasts. Placenta 2008; 29:871878.
  • 16
    Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19:683765.
  • 17
    Bennet WA, Lagoo-Deenadayalan S, Whitworth NS, Brackin MN, Hale E, Cowan BD: Expression and production of interleukin-10 by human trophoblast: relationship to pregnancy immunotolerance. Early Pregnancy 1997; 3:190198.
  • 18
    Murphy SP, Fast LD, Hanna NN, Sharma S: Uterine NK cells mediate inflammation-induced fetal demise in IL-10 null mice. J Immunol 2005; 175:40484090.
  • 19
    Murphy SP, Hanna NN, Fast LD, Shaw S, Berg G, Padbury JF, Romero R, Sharma S: Evidence for participation of uterine natural killer cells in the mechanism responsible for spontaneous preterm labor and delivery. Am J Obstet Gynecol 2009; 200:e1e9.
  • 20
    Thaxton JE, Romero R, Sharma S: TLR9 activation coupled to IL-10 deficiency induces adverse pregnancy outcomes. J Immunol 2009; 183:11441154.
  • 21
    Thaxton JE, Sharma S: Interleukin 10: a multi-faceted agent of pregnancy. Am J Reprod Immunol 2010; 63:482491.
  • 22
    Tewari N, Kalkunte S, Murray DW, Sharma S: The water channel aquaporin is a novel molecular target of polychlorinated biphenyls for in utero abnormalities. J Biol Chem 2009; 284:1522415232.
  • 23
    Tinsley JH, Chiasson VL, Mahajan A, Young KJ, Mitchell BM: Toll-like receptor 3 activation during pregnancy elicits preeclampsia-like symptoms in rats. Am J Hypertens 2009; 22:13141319.
  • 24
    Lai Z, Kalkunte S, Sharma S: A critical role of IL-10 in modulating hypoxia-induced preeclampsia-like disease in mice. Hypertension 2011; 57:505514.
  • 25
    Wong AYH, Shathiyah K, Whiteley KJ, Qu D, Langille BL, Adamson SL: Maternal cardiovascular changes during pregnancy and postpartum. Am J Physiol Heart Circ Physiol 2002; 282:H918H925.
  • 26
    Ahokas RA, Sibai BM, Anderson GD: Lack of evidence of a vasodepressor role for relaxin in spontaneously hypertensive and normotensive pregnant rats. Am J Obstet Gynecol 1989; 161:618622.
  • 27
    Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PC: A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973; 52:26822689.
  • 28
    Novak K, Kaufman S: Effects of pregnancy, estradiol, and progesterone on pressor responsiveness to angiotensin II. Am J Physiol Regul Integr Comp Physiol 1991; 261:R1164R1170.
  • 29
    Burke SD, Barrette VF, Bianco J, Thorne JG, Yamada AT, Pang SC, Adams MA, Croy BA: Spiral arterial remodeling is not essential for normal blood pressure regulation in pregnant mice. Hypertension 2010; 55:729737.
  • 30
    Barhoumi T, Kasal DA, Li MW, Shbat L, Laurant P, Neves MF, Paradis P, Schriffin EL: T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury. Hypertension 2011; 57:469476.
  • 31
    Valencia X, Lipsky PE: CD4+CD25+Foxp3+ regulatory T cells in autoimmune diseases. Nat Clin Pract Rheumatol 2007; 3:619626.
  • 32
    Burke SD, Barrette VF, Gravel J, Carter ALI, Hatta K, Zhang J, Chen Z, Leno-Duran E, Bianco J, Leonard S, Murrant C, Adams MA, Croy A: Uterine NK cells, spiral artery modification and the regulation of blood pressure during mouse pregnancy. Am J Reprod Immunol 2010; 63:472481.
  • 33
    Thadhani R, Mutter WP, Wolf M, Levine RJ, Taylor RN, Sukhatme VP, Ecker J, Karumanchi SA: First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 2004; 89:770775.
  • 34
    Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA: Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350:672683.
  • 35
    Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, Kusanovic JP, Gotsch F, Erez O, Mazaki-Tovi S, Gomez R, Edwin S, Chaiworapongsa T, Levine RJ, Karumanchi SA: A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008; 21:923.
  • 36
    Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D’Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA: Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006; 12:642649.
  • 37
    Zhou CC, Irani RA, Dai Y, Blackwell SC, Hicks MJ, Ramin SM, Kellems RE, Xia Y: Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia. J Immunol 2011; 186:60246034.
  • 38
    Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, Van Asshe A: A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 1994; 101:669674.
  • 39
    Sasaki Y, Darmochwal-Kolarz D, Suzuki D, Sakai M, Ito M, Shima T: Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in preeclampsia. Clin Exp Immunol 2007; 149:139145.
  • 40
    Santer-Nanan B, Peek MJ, Khanam R, Richards L, Zhu E, Fazekas de St Groth B: Systemic increase in the ratio between foxp3+ and IL-17 producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J Immunol 2009; 183:70237030.
  • 41
    Prin JR, Boelens HM, Heimweg J, Van der Heide S, Dubois AE, Van Oosterhout AJ: Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood. Hypertens Pregnancy 2009; 61:398.
  • 42
    Kalkunte S, Boij R, Norris W, Friedman J, Lai Z, Kurtis J: Sera from preeclampsia patients elicit symptoms of human disease in mice and provide a basis for an in vitro predictive assay. Am J Pathol 2010; 177:23872398.
  • 43
    Kalkunte S, Nevers T, Norris WE, Sharma S: Vascular IL-10: a protective role in preeclampsia. J Reprod Immunol 2011; 88:165169.
  • 44
    Norris W, Nevers T, Sharma S, Kalkunte S: Review: hCG, preeclampsia and regulatory T cells. Placenta 2011; 32:S182S185.
  • 45
    Ness R, Sibai BM: Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006; 195:4049.
  • 46
    Sullivan SD, Umans JG, Ratner R: Hypertension complicating diabetic pregnancies: pathophysiology, management, and controversies. J Clin Hypertens 2011; 13:275284.